Spectranetics Corporation Appoints Thomas Rasmussen Vice President of Clinical Affairs

February 15, 2008 |

1 min read

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Spectranetics Corporation (Nasdaq: SPNC) today announced it has appointed Thomas M. Rasmussen as Vice President of Clinical Affairs.

Earnings

MORE ON THIS TOPIC

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

Takeda Slashes US Headcount, Hitting Neuro Commercial Teams Hard

January 19, 2026

·

46 min read

·

BioSpace Editorial Staff

Vintage steam train with ancient locomotive and old carriages runs on the tracks in the countryside

IPO

2026 IPO Train Keeps Chugging as AgomAb, SpyGlass Eye Nasdaq Debut

January 19, 2026

·

2 min read

·

Tristan Manalac

Illustration showing hands holding arrow that goes up and down a few times and ends up in upward direction

Obesity

Novo Rises as Oral Wegovy Reaches Over 3,000 Patients in First Week of Launch

January 19, 2026

·

1 min read

·

Tristan Manalac

Illustration showing finger pointing people to leave

Layoffs

Vedanta ‘Significantly’ Reduces Staff, Focuses on Phase III Study of C. Diff Drug

January 16, 2026

·

2 min read

·